We are live on ! Find out more
INZY

Inozyme Pharma
INZY

Delisted

INZY was delisted on the 30th of June, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of INZY yet.

INZY Hedge Fund Activity: Q3 2025 in Review

0 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Inozyme Pharma (INZY) for Q3 2025, worth a combined $0 — down 100% from $202M a quarter earlier.

Sellers outnumbered buyers: 86 funds closed out of INZY and 0 opened new positions — a net loss of 86 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Beryl Capital Management, exiting entirely with an estimated $25.3M sold.

  • 0 institutional investors held Inozyme Pharma (INZY) as of Q3 2025, down from 86 in Q2 2025.
  • Funds reported $0 of Inozyme Pharma stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Inozyme Pharma positions in Q3 2025 and 86 closed out, a net change of -86 holders.
  • The largest Inozyme Pharma seller in Q3 2025 was Beryl Capital Management, an estimated $25.3M sold.

Based on aggregated 13F filings for Q3 2025.